Douglas Earl Martin, SVP of Allogene Therapeutics ALLO, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $40.3K. The latest trade was on 02/02.

DM

DM

Douglas Earl Martin

SVP, General Counsel

Company

Allogene Therapeutics ALLO

First filing

23/08/17

Trades

12 trades

Buys / sales

0 / 2

12-month net buying

−$40.3K

Last trade

02/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Allogene TherapeuticsALLO	Open-market sale	02/02	02/04	22,900 sh	$1.76	$40,304	−3.9%
Allogene TherapeuticsALLO	Open-market sale	25/02/03	25/02/05	6,404 sh	$1.71	$10,950.84	−1.1%